Elaine Corbett

Ph.D.

Director, Strategic Partnerships

Elaine Corbett
Driven by a passion for innovation and making a difference, I find myself lucky enough to work with many amazing stakeholders every day to help make that innovation happen.
Dr. Elaine Corbett joined Ontario Genomics in July 2014. Currently, she is responsible for leading and managing the Strategic Partnership team. Elaine is responsible for developing and leveraging strategic partnerships and common interests with provincial, national and international public and private sector organizations (industries, foundations, government departments, angel investors, VCs etc.) to enable Ontario Genomics’ strategic plan and support synergistic advancement of genomics and engineering biology solutions across Ontario’s priority bio-economic sectors. She has spearheaded strategic reports and partnership opportunities to advance the genomics and engineering biology ecosystem in Ontario and Canada, including driving key initiatives to support the cellular agriculture and biomanufacturing ecosystems more broadly.

Elaine brings over 15 years of progressive leadership experience, working in industry, not-for-profit and academic sectors. Before joining Ontario Genomics, Elaine was a Project Manager at SQI Diagnostics, a Toronto-based biotech company, where she managed multidisciplinary programs for advanced microarray diagnostics. Previously, she was a Senior Field Application Scientist at Axela, a biotech company which develops diagnostic platforms and applications, where her focus was on client management, technical sales and product development.

Elaine received her Honors BSc in Biomedical Science from University College Cork, Ireland. She received her Ph.D. in Biochemistry from the Faculty of Medicine and Dentistry at the University of Alberta, where her work focused on the endoplasmic reticulum and the chaperones involved in protein folding and completed a postdoctoral fellowship in the Cell Biology Program at the Hospital for Sick Children, Toronto, Ontario, where her work focused on cell-mediated immunity and phagocytosis.